Using the Immune System to Treat Cancer
Ronald Levy, MD, the Robert K. and Helen K. Summy Professor and Associate Director of Translational Science at the Stanford Cancer Institute
Moderated by: Melissa Bondy, PhD, Chair of the Department of Epidemiology and Population Health and the Stanford Medicine Discovery Professor at Stanford University School of Medicine
Immunotherapy is revolutionizing the treatment of lymphoma and many other cancers. Cancer researcher and immunotherapy pioneer Dr. Ronald Levy discusses how scientists today are engaging the immune system to treat cancer. Learn about his groundbreaking early work on using antibodies as personalized anti-cancer drugs and the development of the first monoclonal antibody therapy for cancer, rituximab, which is widely used to treat and often cure lymphoma. And discover what’s to come: developing antibodies that take the brakes off the immune system, engineering specially targeted cells to attack cancer cells, and developing in situ therapeutic vaccination of cancer.
Part of Health Matters, Stanford Medicine's free community day. Learn more at healthmatters.stanford.edu. #healthmatters2022
